Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic fo...(elopment programs may be found online at...),Health
Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox
Date:11/6/2009
elopment programs may be found online at http://www.chimerix-inc.com.
SOURCE Chimerix, Inc.
'/>"/>
| SOURCE Chimerix, Inc. Copyright©2009 PR Newswire. All rights reserved |
Related medicine technology :
1. Chimerix Initiates a Multi-dose Clinical Trial of the Companys Lead Compound, CMX001, for the Treatment for Smallpox Infection
2. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
3. Diamyd Updates Gene Therapy Program and Outlines Plans for Phase I Clinical Trial for Treatment of Cancer Pain
4. Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program
5. Wyeth Presents New Phase 3 Data and Updates Regulatory Timing for NDA Filing of Bazedoxifene/Conjugated Estrogens
6. Alliance Pharmaceutical Corp. Updates Oxygent(TM) Clinical Development Plan
7. Imaging Diagnostic Systems Updates PMA Filing Status for the New CT Laser Breast Imaging System
8. BioCryst Updates Peramivir Clinical Development Plan
9. Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program
10. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
11. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
Post Your Comments:
(Date:11/25/2009)...therlandsandJOHANNESBURG,November25/PRNewswire/--,...overyannouncedtoday,thattheyhavesignedacollaborati... , Pyxis,sworldclasscomputationalchemistryand...ervicedivisiontoprovidemedicinaland,syntheticchemi...nationalclientnetwork.iThembaPharmaceuticalsandPyx...
(Date:11/24/2009)...Nov.24/PRNewswire/-- ,, WHAT:RomHoubens,aBelgia...toaccident,wasactuallyfullyconsciousandawakeduring...nt.TheDynaVoxEyeMaxwasfeaturedinthesegmenttoillust...nscanunlockcommunication. ,, WHEN:GoodMorningAm...w.dynavoxtech.com ,, WHO:RomHoubenswasaneng...
(Date:11/24/2009)...v.24/PRNewswire-FirstCall/--AnadysPharmaceuticals,...atthe21stAnnualPiperJaffrayHealthcareConferenceonT...econferenceisbeingheldatTheNewYorkPalaceHotel.Stev...Anadys,willprovideanoverviewofAnadysanditsclinical...oratepresentationwillbesimultaneouslywebcastandcan...
Breaking Medicine Technology:iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2Angiotech Pharmaceuticals announces the commercial launch of the Option 28TM 29 Inferior Vena Cava Filter in the United States 13637 1Angiotech Pharmaceuticals announces the commercial launch of the Option 28TM 29 Inferior Vena Cava Filter in the United States 13637 2Angiotech Pharmaceuticals announces the commercial launch of the Option 28TM 29 Inferior Vena Cava Filter in the United States 13637 3Angiotech Pharmaceuticals announces the commercial launch of the Option 28TM 29 Inferior Vena Cava Filter in the United States 13637 4Angiotech Pharmaceuticals announces the commercial launch of the Option 28TM 29 Inferior Vena Cava Filter in the United States 13637 5WorldHeart Receives US Clinical Study Approval for the Levacor 28TM 29 VAD 4876 1WorldHeart Receives US Clinical Study Approval for the Levacor 28TM 29 VAD 4876 2WorldHeart Receives US Clinical Study Approval for the Levacor 28TM 29 VAD 4876 3Impax Pharmaceuticals Selects OmniComm Systems to Provide eClinical Solutions for International Phase III Study in Parkinsons Disease 4874 1Impax Pharmaceuticals Selects OmniComm Systems to Provide eClinical Solutions for International Phase III Study in Parkinsons Disease 4874 2Impax Pharmaceuticals Selects OmniComm Systems to Provide eClinical Solutions for International Phase III Study in Parkinsons Disease 4874 3[0] iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering[0] DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years[0] Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference
...NCOUVER, June 21, 2007 /PRNewswire-FirstCall/ - Bi...ederation has given,Biotech,s "Sucanon" diabetes d...ublished in the May-June 2007 issue of Diabetes,Ho...l magazine for,doctors and other health profession...Dr. Roberto Cepeda,Gonzalez, Medical Director of t...
...COLNSHIRE, Ill.--(BUSINESS WIRE)--Jun 21, 2007 - B...vided comment on the,Women,s Health Initiative (WH...ay in The New England Journal of Medicine (NEJM).,...d 50-59) who,received a standard dose of estrogen ...cification at the end of the study period,compared...
Other Medicine Technology:Diabetes drug supported by Mexican Diabetes Federation 2Diabetes drug supported by Mexican Diabetes Federation 3New Analysis of WHI Data Shows Reduced Levels of Coronary Artery,Calcification, a Predictor of Cardiovascular Events, in Women aged,50-59 taking Estrogen Therapy 2New Analysis of WHI Data Shows Reduced Levels of Coronary Artery,Calcification, a Predictor of Cardiovascular Events, in Women aged,50-59 taking Estrogen Therapy 3New Analysis of WHI Data Shows Reduced Levels of Coronary Artery,Calcification, a Predictor of Cardiovascular Events, in Women aged,50-59 taking Estrogen Therapy 4(Date:11/25/2009)...,Minn.,Nov.25/PRNewswire-USNewswire/--Whenmostpeop...iropractorcanalsogivepatientsthehelptheyneed.TMJst...rjaw(mandible)contacts/connectswithyourskull(tempo...hTMJdysfunctionarepainwithchewing,clickingorpoppin...sfunctionincluding:headaches,fatigue,sleepdisturba...
(Date:11/25/2009)...TO,Nov.25/PRNewswire/-SentinelleMedicalInc.,aleadi...tionsoftwarelaunchesasuiteofnewleadingedgeclinical...atformatthisyear,sRadiologicalSocietyofNorthAmeric...oth5800,HallA).Theapplicationsleveragetheuniquehig...Iimagingcoilsandsupportmultipleimagingmodalitiesfo...
(Date:11/25/2009)...ANCISCO,Nov.25/PRNewswire/--TheBayAreaAirQualityMa... Spare the Air Alert forThursday,Novem...soranyothersolidfuel,bothindoorsandoutdoors. ,,...litytomorrow,"saidJackBroadbent,executiveofficerof...ctthehealthoftheirneighborsandfellowcommunitymembe...
(Date:11/25/2009)...ous discovery that grew out of a collaboration bet...ly offer hope to the nearly 10 million Americans w... Also known as hardening of the arteries, periphe...ory problem in which narrowed arteries reduce bloo... red flag for vascular disease, heart attack and s...
(Date:11/25/2009)... Evaluation and treatment clinics to r...oodstock (Vocus) November 25, 2009 -- Centegra Hea...nes and H1N1 vaccine shots at four Centegra Primar...pment of vaccine has arrived. The clinics are at C...cHenry and will be open as follows: , ...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4[1] TMJ and Chiropractic Care: An Overall Wellness Approach[1] Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology[0] Winter Spare the Air Alert in Effect for Thursday, November 26, 2009[1] Engineers, doctors at UCLA develop novel material that could help fight arterial disease[0] Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1
... Exposure to estrogens in the early stages of the ...s is a factor cited by the scientists for the deve...f life. //
The study, done in an animal mode... of estrogens (xenoestrogens) are widespread in th...
... Students of Delhi University will soon be evaluat...cademic reform measures being introduced. //
...ancellor earlier this year, the academic reform co... top priorities for the committee and we want to m...
... Medical services in state-run hospitals across th...to work after 20 days of anti-quota protests follo...OPD services in premier health institutions like A...government hospitals in West Bengal, Karnataka, Ut...
... With the medicos' agitation against reservation c... withdraw it // , the casualty ward of the MKCG Me... a group of people who alleged that negligence cau...
'We brought him to the hospital immediately af...
... India and Singapore have agreed to cooperate in s...ism, //money laundering, organized crime and drugs...agement.
"The two sides decided to cooperate ...ment," a senior official told PTI Wednesday here.
...
... New Delhi. Taking serious note of the plight of ... protesting medicos to call off their strike //for...tive action against them.
Observing that the...orm of dissent.
"Whatever Government does is ...
Other Medicine News:Health News:Prostate Cancer Risk Linked To Early Estrogen Exposure 2Health News:Students to Evaluate the Performance of Teachers 2Prostate Cancer Risk Linked To Early Estrogen ExposureStudents to Evaluate the Performance of TeachersHealth Services Returning To NormalMedicos Stir On, Hospital Ransacked After Patients DeathIndia & Singapore Join hands to Fight Terror & Drug TraffickingNo Punitive Action Against Striking Medicos if Strike Called Off
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |